Cannabis Disorder
Cannabis use disorder (CUD), also known as cannabis addiction or marijuana addiction, is defined in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and ICD-10 as the continued use of cannabis despite clinically significant impairment.
Cluster Number:
Wiki Number: W033
Diagnosis: Cannabis (Marijuana) Use Disorder
US Patients:
World Patients :
Sex Ratio:
Age Onset:
Brain Area:
Symptoms: develops tolerance, requiring increased use, 15% of daily users become addicted
Progression: withdrawal, tolerance, use of time, cravings;1/3 of users transition to schizophrenia
Causes:
Medications: None with consistent, positive results; 9% of users become dependent.
Therapies:
Youtube Video: Cannabis Use Disorder
Amazon or Library Book: Quitting Weed
Click the book to link or order from Amazon.
Support Group: marijuana-anonymous/find-a-meeting; Online
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Cannabis sativa extracts inhibit LDL oxidation and the formation of foam cells in vitro, acting as potential multi-step inhibitors of atherosclerosis developmentby Bruno Musetti on December 20, 2024
Atherosclerotic disease is the leading cause of death world-wide. Our goal was to explore the effect of phytocannabinoids on the molecular mechanisms triggering the development of the atheromatous lesion. Three cannabis sativa extracts of different chemotypes were chemically characterized by UPLC-DAD. The capacity of the extracts to prevent the oxidation of LDL, the formation of foam cells and the activation of an inflammatory response by J774 cells, were monitored by UV-Vis spectrometry,...
- Developing an HIV-specific falls risk prediction model with a novel clinical index: a systematic review and meta-analysis methodby Sam Chidi Ibeneme on December 19, 2024
CONCLUSION: Our meta-analysis identifies predictors of falls in people living with HIV, emphasizing physiological, behavioral, and HIV-specific factors. Integrating these into clinical practice could mitigate falls-related sequelae. We propose a novel approach to falls risk prediction using a novel clinical index, resulting in a HIV-specific falls risk assessment tool.
- Cannabinoids for treating psychiatric disorders in youth: a systematic review of randomized controlled trialsby Patrick Köck on December 19, 2024
CONCLUSION: While meta-analysis of effect sizes for primary outcomes revealed modest positive effects, particularly for autism spectrum disorders, the current evidence remains insufficient to broadly recommend cannabinoids for treating mental disorders in youth populations. Larger, controlled studies with standardized outcomes are needed to establish definitive clinical recommendations.
- Cannabis Vaping Is Associated With Past 30-Day Suicide Attempts and Suicidal Ideation Among Adolescents in a Psychiatric Inpatient Settingby Sarah A Thomas on December 19, 2024
CONCLUSION: Vaping as the most frequent method of CU was significantly associated with suicide attempts and SI. Because data are cross-sectional, causality cannot be inferred. Nonetheless, cannabis vaping is important to assess among adolescents with acute psychiatric concerns because it may place them at higher risk for suicidal thoughts and attempts.